Huang, James; Osarogiagbon, Raymond U; Giroux, Dorothy J; Nishimura, Katherine K; Bille, Andrea; Cardillo, Giuseppe; Detterbeck, Frank; Kernstine, Kemp; Kim, Hong Kwan; Lievens, Yolande; Lim, Eric; Marom, Edith; Prosch, Helmut; Putora, Paul Martin; Rami-Porta, Ramon; Rice, David; Rocco, Gaetano; Rusch, Valerie W; Opitz, Isabelle; Vasquez, Francisco Suarez; ... (2024). The IASLC Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 9th Edition of the TNM Classification for Lung Cancer. Journal of thoracic oncology, 19(5), pp. 766-785. Elsevier 10.1016/j.jtho.2023.10.012
Text
1-s2.0-S1556086423023109-main.pdf - Accepted Version Restricted to registered users only until 20 October 2024. Available under License Publisher holds Copyright. Download (1MB) |
INTRODUCTION
The accurate assessment of nodal (N) status is crucial to the management and prognostication of non-metastatic non-small cell lung cancer. We sought to determine whether the current N descriptors should be maintained or revised for the upcoming 9th edition of the international Tumor Node Metastasis (TNM) lung cancer staging system.
METHODS
Data was assembled by the International Association for the Study of Lung Cancer on patients with non-small cell lung cancer, detailing both clinical and pathologic N status, with information about anatomic location and individual station-level identification. Survival was calculated by the Kaplan-Meier method and prognostic groups were assessed by a Cox regression analysis.
RESULTS
Data for clinical N and pathologic N status were available in 45,032 and 35,009 patients, respectively. The current N0 to N3 descriptors for both clinical N and pathologic N categories demonstrated prognostically distinct groups. Furthermore, single station N2 involvement (N2a) demonstrated better prognosis than multistation N2 involvement (N2b) in both clinical and pathologic classifications, and the differences between all neighboring nodal subcategories were highly significant. The prognostic differences between N2a and N2b were robust and consistent across resection status, histologic type, T category, and geographic region.
CONCLUSIONS
The current N descriptors should be maintained, with the addition of new sub-descriptors to N2 for single station involvement (N2a) and multiple station involvement (N2b).
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Radiation Oncology |
UniBE Contributor: |
Putora, Paul Martin |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1556-1380 |
Publisher: |
Elsevier |
Language: |
English |
Submitter: |
Pubmed Import |
Date Deposited: |
23 Oct 2023 13:56 |
Last Modified: |
10 May 2024 00:12 |
Publisher DOI: |
10.1016/j.jtho.2023.10.012 |
PubMed ID: |
37866624 |
Uncontrolled Keywords: |
Lung cancer Lung cancer staging Lymph node metastasis N component N descriptors TNM classification |
BORIS DOI: |
10.48350/187366 |
URI: |
https://boris.unibe.ch/id/eprint/187366 |